710-1166

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
710 (USA) · Dr. Silva
consented 2012-11-30

AEs

Serious

Dropout signal

–

Adverse events

moderate assessed

Moderate COMPLEX PARTIAL SEIZURES — outcome: RECOVERED/RESOLVED; onset 2013-03-19 (study day 110.0); relationship: POSSIBLE; serious criteria: hospitalization

moderate assessed

Moderate FALL — outcome: RECOVERED/RESOLVED; onset 2013-03-19 (study day 110.0); relationship: POSSIBLE

moderate assessed

Moderate SKIN LACERATION — outcome: RECOVERED/RESOLVED; onset 2013-03-19 (study day 110.0); relationship: POSSIBLE

moderate assessed

Moderate SYNCOPE — outcome: RECOVERED/RESOLVED; onset 2013-03-19 (study day 110.0); relationship: POSSIBLE

moderate assessed

Moderate SYNCOPE — outcome: RECOVERED/RESOLVED; onset 2013-03-20 (study day 111.0); relationship: POSSIBLE; serious criteria: hospitalization

Data queries

No data queries.